Kevin Kimberlin

Chairman of Spencer Trask & Co. Helped start ventures that created and commercialized landmark products in cancer genomics, immunotherapy and cellular therapy. Myriad Genetics discovered the BRCA1 breast cancer gene. His Immune Response Corporation venture with Jonas Salk developed the first FDA-approved cancer vaccine. Osiris Therapeutics created the world’s first approved universal stem cell drug. As a founding shareholder in Bob Langer’s first company, Enzytech (Alkermes), Kimberlin observed how Langer’s lipid research came to protect the mRNA in Moderna’s COVID-19 vaccine.